Rchr
J-GLOBAL ID:200901054609054280   Update date: Oct. 24, 2021

Owaki Toshiyuki

Owaki Toshiyuki
Research theme for competitive and other funds  (5):
  • 2018 - 2021 Inhibition of pulmonary fibrosis by mesenchymal stem cells through IL-27 and its clinical application
  • 2017 - 2020 抑制性サイトカインIL-27とIL-35による間葉系幹細胞の治療効果の増強
  • 2014 - 2018 Study of possibility of discrimination of personae using biological censors
  • 2007 - 2012 接着分子をターゲットとした治療薬の創製
  • 2007 - 2012 New drug development for cell adhesion molecule-targeting therapy
Papers (22):
more...
MISC (94):
more...
Lectures and oral presentations  (81):
  • Chemosensitization of Malignant Tumor Cells to Anticancer Drugs through β1-integrin Activation
    (8th Pan-Pacific Connective Tissue Societies Symposium 2009)
  • Promotion of PDGF-dependent cell proliferation through β1-integrin activation
    (8th Pan-Pacific Connective Tissue Societies Symposium 2009)
  • Sustained Activation of β1-Integrins induces Proliferative Arrest or Apoptosis in Fibroblasts
    (8th Pan-Pacific Connective Tissue Societies Symposium 2009)
  • オートファジー誘導に基づく結核菌殺滅に関する基礎的研究
    (日本薬学会第129年会 2009)
  • 反接着ペプチドによる接着依存性薬剤耐性(CAM-DR)の克服
    (日本薬学会第129年会 2009)
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page